{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the titles and passages are a bit confusing. Let me check again.\n\nThe context has four entries. The first three are just the title \"Estimating the number of infections and the impact of non-\" followed by \"Passage: Lockdown\". The fourth one is \"Title: Estimating the number of infections and the impact of non- Passage: banned Implemented with lockdown.57 24/3/2020\". Hmm, maybe there's a formatting issue here. The titles seem incomplete, like they were cut off. The fourth passage mentions \"banned Implemented with lockdown.57 24/3/2020\". The date might be March 24, 2020, which is when many countries started lockdowns during the pandemic.\n\nSo, the user wants an answer based on the context provided. But the context is a bit fragmented. The main keywords are \"lockdown\" and \"non-lockdown\". The fourth passage mentions \"banned Implemented with lockdown\", which might mean that certain measures were banned and replaced with lockdowns. The date 24/3/2020 is significant because that's when the UK, for example, implemented a strict lockdown.\n\nPutting this together, a lockdown is a public health measure where people are required to stay at home, non-essential businesses close, and movement is restricted to control the spread of a disease, like COVID-19. The context suggests that lockdowns were implemented to estimate their impact on reducing infections compared to non-lockdown measures. The mention of \"banned\" might refer to the closure of certain activities. The answer should define lockdown in this context, possibly referencing the date as an example of when it was implemented.\n</think>\n\nA **lockdown** is a public health measure implemented to restrict movement and gatherings of people in order to slow the spread of a contagious disease, such as during the COVID-19 pandemic. It typically involves closing non-essential businesses, schools, and public spaces, and limiting travel to essential activities only. The context provided references the implementation of lockdown measures (e.g., on 24 March 2020) as part of efforts to estimate their impact on reducing infections compared to non-lockdown strategies.",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know stands for Chikungunya virus. Let me look back at the provided context to find the answer.\n\nFirst, the passage mentions several groups affected: over 50% of severe cases are in people over 65, and children are also disproportionately affected. Then, under the complications, it lists them from most common to least. The main part I need is the list of complications. Let me check again.\n\nThe passage says: \"Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.\" \n\nSo those are the complications. Also, there's a mention of neonates having symptoms and some developing meningoencephalitis. Wait, the neonates part is about transmission from mothers, leading to symptoms like CHIKF and specifically meningoencephalitis in six cases. But the main list of complications is already given in the first part. \n\nI need to make sure I include all the complications listed. Let me list them again:\n\n1. Respiratory failure\n2. Cardiovascular decompensation\n3. Meningoencephalitis\n4. Severe acute hepatitis\n5. Severe cutaneous effects\n6. Other central nervous system problems\n7. Kidney failure\n\nAdditionally, the neonates part mentions that some develop meningoencephalitis, but that's already included in the list. So the answer should include all these complications as per the passage. I should present them in order from most common to least as stated. Also, note that underlying medical conditions in adults contribute to severe cases. But the question is specifically about complications, so the list above is the key.\n</think>\n\nThe complications associated with CHIKV (Chikungunya virus) include:  \n1. **Respiratory failure**  \n2. **Cardiovascular decompensation**  \n3. **Meningoencephalitis**  \n4. **Severe acute hepatitis**  \n5. **Severe cutaneous effects**  \n6. **Other central nervous system problems**  \n7. **Kidney failure**  \n\nAdditionally, neonates born to infected mothers may develop **meningoencephalitis** and",
      "retrieved_chunks": [
        "Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "Title: Chikungunya: A Potentially Emerging Epidemic?",
        "Title: Chikungunya: A Potentially Emerging Epidemic?",
        "Title: Chikungunya: A Potentially Emerging Epidemic?"
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.2,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what the answer is here. The user is asking, \"What does Clade A contain?\" based on the provided context. Let me start by reading through the context carefully.\n\nFirst, the context mentions several clades like 1B.1, 1B.2, 1A.1, 1A.1.1, and 1C. The main text talks about a phylogeny-based nomenclature system for H1 hemagglutinin genes in swine influenza A viruses. The passages discuss different lineages, such as 1A and 1C, with specific numbers of viruses from various countries. \n\nLooking at the first passage, it says the 1A lineage has 1,889 viruses from 34 countries collected from 2010 to the present. It was refined into three second-order divisions. The second passage about 1C lineage has 315 viruses from 14 countries in China and South Korea. There's also mention of \"Other-Avian\" clades related to 1C.\n\nThe question is about Clade A. However, in the provided context, the main clades discussed are 1A, 1B, 1C, and their subclades like 1A.1, 1B.1, etc. There's no mention of a clade labeled simply \"A.\" The 1A lineage is a first-order clade, and within it, there are subclades like 1A.1 and 1A.1.1. Similarly, 1B and 1C are first-order clades. \n\nThe user might be confusing \"Clade A\" with the 1A lineage. Since the context doesn't mention a standalone \"Clade A,\" but does talk about 1A, 1B, 1C lineages, it's possible that the answer is that Clade A isn't mentioned in the provided context. Alternatively, if there's a typo and they meant 1A, then the answer would be the 1A lineage containing 1,889 viruses from 34 countries. But since the question specifically says \"Clade A,\" and the context refers to \"1A,\" \"1B,\" etc., I should check if there's any mention of \"A\" elsewhere. \n\nLooking again, the",
      "retrieved_chunks": [
        "For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting.",
        "Title: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1A swine lineage. The 1A lineage contained 1,889 viruses from 34 countries collected from 2010 to the present . According to our nomenclature rules, we refined the classification of 1A viruses into three second-order divisions, each of which corresponds to earlier, regional classifica- Table 2 .",
        "Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 ."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look at the provided context. The passage mentions that the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. The key part here is the \"70% identity,\" which indicates a moderate level of similarity. \n\nAlso, there's a note about the receptor binding domain (RBD) in the spike protein. The context states that most bat SARS-related CoVs have two stretches of deletions in the RBD compared to human SARS-CoV. However, the passage says that the core domain of the RBD is highly conserved. This suggests that even though there are some differences in the RBD regions, the core part remains similar.\n\nThe S2 subunit is mentioned as being highly conserved with 99% identity, but the question is about S1. The S1 subunit is responsible for receptor binding, so differences here could affect how the virus interacts with host cells. The 70% identity implies that there are significant differences, but the core RBD is conserved, which might mean that the virus can still bind to ACE2 receptors similarly to SARS-CoV, despite other variations.\n\nI should also consider the mention of structures like SL1 to SL5. The passage notes that these structures are similar among 2019-nCoV, human SARS-CoV, and bat ZC45. However, the S5 part in 2019-nCoV is located within orf1a/b like SARS-CoV, whereas in ZC45 it's not. This structural similarity might relate to the S1 subunit's function or stability.\n\nPutting it all together, the S1 subunit of 2019-nCoV has about 70% identity with SARS-like CoVs and human SARS-CoV. The RBD core is conserved, but there are deletions in bat CoVs. The S1 subunit's lower identity compared to S2 (which is 99%) shows that S1 is more variable. This variability might be important for immune evasion or host adaptation",
      "retrieved_chunks": [
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b.",
        "Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus."
      ],
      "computed_relevance": 0.14285714285714285,
      "computed_utilization": 0.14285714285714285,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and they provided some context from a passage. I need to use the information given to form an accurate answer.\n\nFirst, I'll look through the context provided. The first part mentions that Bacillus subtilis helps retain gut barrier integrity, decreases endotoxin concentration, and reduces gut inflammation, citing a study by Bene et al., 2017. That's important because it shows its role in gut health.\n\nThe second part of the context talks about how Bacillus species, including subtilis, are found in traditional fermented foods and are used in probiotics like Enterogermina, Biosubtyl, etc. It also mentions that they produce surfactins, fengycins, and iturins in a specific ratio (6:37:57). These are likely antimicrobial peptides or compounds that contribute to their beneficial effects.\n\nAnother part of the passage notes that unlike Lactobacillus, Bacillus species weren't traditionally considered part of the normal intestinal microbiome, but they are used in probiotics. The passage also mentions their presence in environments like decomposing plants.\n\nPutting this together, Bacillus subtilis is a species of Bacillus that's used as a probiotic. It's found in fermented foods and has health benefits for the gut, such as maintaining barrier function and reducing inflammation. It produces certain compounds (surfactins, fengycins, iturins) that contribute to its antimicrobial properties. It's part of probiotic products and is applied in food industry as well.\n\nI need to make sure the answer includes its role as a probiotic, its benefits to gut health, the compounds it produces, and its use in fermented foods and probiotics. Also, mention that it's a spore-forming bacterium since Bacillus species are known for that. The answer should be concise but cover all these points based on the context provided.\n</think>\n\nBacillus subtilis is a spore-forming bacterium commonly found in soil and associated with decomposing plant matter. It is widely recognized for its probiotic properties and is used in traditional fermented foods and commercial probiotic products (e.g., Enterogermina, Biosubtyl). Key characteristics include its ability to produce antimicrobial compounds like surfactins, fengycins, and iturins (in a",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis also retained gut barrier integrity, decreased the endotoxin concentration and reduced gut inflammation Bene et al., 2017) .",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 .",
        "In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B."
      ],
      "computed_relevance": 0.375,
      "computed_utilization": 0.375,
      "computed_completeness": 0.6666666666666666,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context titled \"The origins of the great pandemic,\" it mentions the 1889 pandemic having three major waves, with the 1892 wave being the most intense. However, the question is about single-wave pandemics, so this might not be directly relevant. But there's a mention of the 1918 pandemic's herald waves possibly stretching back to 1915. The 1918 pandemic is known for having multiple waves, though. Hmm, maybe not directly applicable here.\n\nNext, the second context from Hong Kong discusses the 2009 pandemic influenza A(H1N1). They mention using convalescent plasma and studies on the origin and pathogenesis of the 2009 strain. The 2009 pandemic had multiple waves in some regions, but maybe in certain areas it was a single wave? The context doesn't specify, but the focus is more on their research response rather than the pandemic's wave structure.\n\nThe third context is about economic analysis of mitigation strategies for five pandemic severity categories. It references studies using simulation models, but again, it's about strategies rather than the pandemic's wave patterns. The passage doesn't mention single-wave pandemics specifically.\n\nThe fourth context from Taiwan discusses the 2009 pH1N1 pandemic and mentions multi-wave epidemics, using a Richards model variation to analyze waves. This seems to focus on multi-wave scenarios, so not directly answering the question about single-wave.\n\nPutting this together, the provided contexts don't explicitly mention research on severe, single-wave pandemics. They discuss pandemics with multiple waves (1889, 1918, 2009) and studies related to their origins, interventions, and models. The user's question is about single-wave, but the examples given in the contexts are multi-wave. However, maybe the 1892 wave being the most intense in the first context could be considered a single wave in that region? The passage says \"at least on the East Coast of the USA,\" so perhaps in that specific area, it was a single intense wave. But the overall pandemic had multiple waves globally. \n\nAlternatively, maybe the 2009 pandemic in",
      "retrieved_chunks": [
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave."
      ],
      "computed_relevance": 0.375,
      "computed_utilization": 0.75,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how many reported viral pneumonia cases there were based on the provided context. Let me go through each passage carefully.\n\nFirst, looking at the passage about the 2019-nCoV guideline, it mentions that as of January 26, 2020, there were 2744 confirmed cases of pneumonia with 2019-nCoV infection. That's a specific number related to viral pneumonia caused by the novel coronavirus. \n\nThen, there's another passage about the 2009 H1N1 pandemic in La Gloria, Veracruz, which mentions clinical attack rates but doesn't give exact numbers of cases. The other passages talk about bacterial co-infections and antiviral therapy but don't provide specific case numbers. \n\nThe question is asking for the total reported viral pneumonia cases. The only passage that provides a specific number is the one about 2019-nCoV, which states 2744 confirmed cases. The other contexts don't mention specific numbers for viral pneumonia beyond that. The Hong Kong, Macao, and Taiwan mention \"a total of confirmed cases\" but the exact number isn't provided in the given text. So, the answer should be the 2744 cases from the 2019-nCoV passage. I need to make sure there's no other number I missed. Let me check again. The other passages don't have specific numbers for viral pneumonia cases. So the answer is 2744.\n</think>\n\nThe provided context mentions a specific number of confirmed cases related to viral pneumonia in the passage about the 2019-nCoV (now known as COVID-19). As of **24:00 on 26 January 2020**, the National Health Commission of China recorded **2,744 confirmed cases of pneumonia with 2019-nCoV infection**. Other passages discuss influenza-related pneumonia and bacterial co-infections but do not provide specific numerical data on viral pneumonia cases beyond this. \n\n**Answer:** 2,744 reported cases of viral pneumonia (2019-nCoV).",
      "retrieved_chunks": [
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "The most common coinfecting bacterial pathogens were pneumococcus, Staphylococcus aureus, and Streptococcus pyogenes, with a median duration of illness of 6 days ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, the title is about diagnostics, epidemiology, and transmission. The first passage says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. It mentions high throughput or deep sequencing for complete genome studies. \n\nThe other passages talk about things like subgenomic sequencing being less published, variations in the genome, and recombination, but the first passage clearly states the primary method used. The key terms here are \"high throughput\" and \"deep sequencing.\" \n\nI should make sure there's no other method mentioned as the main one. The second passage mentions subgenomic sequencing but says it's been less often published. The third and fourth passages talk about whole genome sequencing being used extensively, but the first passage specifically answers the question about the primary method. \n\nSo the answer should be that high throughput or deep sequencing methods were used for complete genome deduction. I need to phrase it clearly and concisely based on the context provided.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods for complete genome deduction**. This approach was highlighted as the primary technique for studying the virus's genetic makeup during its emergence.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective.",
        "While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided context to find the relevant information.\n\nFirst, looking at the first passage under the title about influenza A viruses. It mentions that GFP was observable in the lungs of infected mice using IVIS for whole-organ imaging. Also, they used flow cytometry to analyze infection progression in antigen-presenting cells. Then, imaging of murine lungs showed the infection starting near large airways and spreading deeper. So IVIS and flow cytometry are methods used here.\n\nThe second passage talks about monitoring plates with an inverted fluorescence microscope for GFP expression. They also generated single-cell clones using puromycin and limiting dilution. But the question is about tracking spread, so maybe the microscope part is relevant here.\n\nThird passage mentions using multi-photon intravital microscopy to visualize cytoplasmic fluorescent proteins. They monitored GFP expression during passaging with immunofluorescence microscopy using a GFP antibody.\n\nPutting it all together, the methods mentioned are IVIS for whole-organ imaging, flow cytometry, fluorescence microscopy (inverted and immunofluorescence), and multi-photon intravital microscopy. The answer should list these techniques as the ways they tracked the spread. Need to make sure to mention each method and maybe the specific contexts they were used in, like IVIS for ex vivo lungs and flow cytometry for analyzing cells.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using multiple imaging techniques. **In vivo and ex vivo monitoring** was conducted via **IVIS (whole-organ imaging)** to observe GFP in infected mouse lungs. **Flow cytometry** was used to analyze infection progression in antigen-presenting cells. Additionally, **fluorescence microscopy** (including inverted fluorescence microscopy and immunofluorescence microscopy with GFP antibodies) was employed to monitor GFP expression in cell cultures and during passaging. For deeper in vivo visualization, **multi-photon intravital microscopy** was utilized to observe cytoplasmic fluorescent proteins in live tissues. These methods collectively enabled tracking of viral spread from initial infection sites (e.g., airways) to deeper lung regions.",
      "retrieved_chunks": [
        "Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs .",
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed .",
        "For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution.",
        "Title: Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy\nPassage: express cytoplasmic fluorescent proteins driven e.g., by the chicken \u03b2-actin promoter with cytomegalovirus enhancer or human ubiquitin C promoter .",
        "Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody."
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 0.7142857142857143,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures.\n\nFirst, I need to parse the context. The titles all mention \"The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\" and the passages talk about noncontaminated CT disinfection procedures after suspected cases, fever-CT disinfection, and preparing to disinfect imaging equipment immediately after examination.\n\nThe key points here are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The passages mention \"immediately after the examination\" and \"sterilization procedures.\" The answer should probably include steps like using appropriate disinfectants, following specific protocols, and ensuring that the equipment is properly cleaned to prevent contamination.\n\nWait, but the context doesn't give detailed steps. It just mentions that they prepare to disinfect immediately after. Maybe the answer is more about the timing and the fact that it's done right after the exam. Also, the terms \"noncontaminated CT disinfection procedures\" might imply that there's a standard protocol they follow. Since the user is asking for the recommended procedure, the answer should be based on the information given in the context, even if it's not very detailed.\n\nSo, putting it together: The recommended procedure is to disinfect the CT scanner immediately after the examination using the established sterilization procedures. The context doesn't specify the exact steps, but emphasizes the timing and the necessity of the process. Maybe mention that it's done right after the exam and that proper equipment is used.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment following the examination** using established sterilization protocols. The context emphasizes that this process should occur promptly after the examination to prevent contamination, ensuring that all equipment is properly cleaned and sterilized according to emergency management guidelines for suspected or confirmed COVID-19 cases. Specific disinfectants or detailed steps are not outlined in the provided context, but the focus is on timely and thorough decontamination.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}